Regencell Bioscience Holdings Limited

Last updated September 27, 2026

Organization details

Legal name
Regencell Bioscience Holdings Limited
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2833 — Medicinal Chemicals & Botanical Products
Jurisdiction of incorporation
Cayman Islands
Headquarters city
Hong Kong
Headquarters country
Hong Kong
Ticker symbol
RGC
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001829667

Board of directors

Chief executives

Yat-Gai Au · Chief Executive Officer
Since March 2026

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Nov 17, 2026 William Wing Yan Lo Director Option exercise +36,001 $0.84 $30,241

Organizations in the same sector, closest in location and size first.

Questions about Regencell Bioscience Holdings Limited

Who is the CEO of Regencell Bioscience Holdings Limited?

Yat-Gai Au has been Regencell Bioscience Holdings Limited's Chief Executive Officer since March 2026.

How many directors are on Regencell Bioscience Holdings Limited's board?

Regencell Bioscience Holdings Limited's board has 5 directors: Evana Yee Wah Hui, James Wai Hong Chung, Margaret Hoor Han Lo, William Wing Yan Lo and Yat-Gai Au.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="regencell-bioscience-holdings-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.